|
Report No. : |
357140 |
|
Report Date : |
28.12.2015 |
IDENTIFICATION DETAILS
|
Name : |
SOCIETE PHARMACEUTIQUE DU CAMEROON SARL |
|
|
|
|
Registered Office : |
Boulevard De La Republique, Bessengue Deido, (Meme B Atiment Que La Direction Macat) BP 15483 Deido Douala |
|
|
|
|
Country : |
Cameroon |
|
|
|
|
Date of Incorporation : |
14.07.2011 |
|
|
|
|
Com. Reg. No.: |
RC/DLA/2011/B/1910 |
|
|
|
|
Legal Form : |
Societe Anonyme Responsabilitee Limitee |
|
|
|
|
Line of Business : |
Importation and
Distribution of Medicines, Drugs and Other Similar Products. |
|
|
|
|
No. of Employees : |
20 Employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Cameroon |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CAMEROON - ECONOMIC
OVERVIEW
Modest oil resources and favorable agricultural conditions
provide Cameroon with one of the best-endowed primary commodity economies in
sub-Saharan Africa. Cameroon’s economy suffers from political and economic
factors that often impact underdeveloped countries, such as stagnant per capita
income, a relatively inequitable distribution of income, a top-heavy civil
service, endemic corruption, the continuing inefficiencies of a large
parastatal system in key sectors, and a generally unfavorable climate for
business enterprise. Since 1990, the government has embarked on various IMF and
World Bank programs designed to spur business investment, increase efficiency
in agriculture, improve trade, and recapitalize the nation's banks. The IMF
continues to press for economic reforms, including increased budget
transparency, privatization, and poverty reduction programs. The Government of
Cameroon provides subsidies for electricity, food, and fuel that have strained
the federal budget diverting funds from education, healthcare, and
infrastructure projects. Cameroon devotes significant resources to several
large infrastructure projects under construction, including a deep sea port in
Kribi and the Lom Pangar Hydropower Project. Cameroon’s energy sector continues
to diversify, recently opening a natural gas powered electricity generating
plant. Oil remains Cameroon’s main export commodity accounting for nearly 40%
of export earnings despite falling global oil prices. Cameroon continues to seek
foreign investment to improve its inadequate infrastructure, create jobs and
improve its economic footprint but its unfavorable business environment remains
a significant deterrent to foreign investment.
|
Source
: CIA |
|
Registered Name: |
SOCIETE
PHARMACEUTIQUE DU CAMEROON SARL |
|
Requested Name: |
SOCIETE PHARMACEUTIQUE DU CAMEROON |
|
Trade Names: |
SPC SARL |
|
Physical Address: |
Boulevard De La Republique, Bessengue Deido, (Meme
B Atiment Que La Direction Macat |
|
Postal Address: |
BP
15483 Deido |
|
|
Douala |
|
Country: |
Cameroon |
|
Phone: |
237-650750705/-33-402838/77885668/99932503 |
|
Fax: |
237-33-402838 |
|
Email: |
s.p.c_2012@yahoo.fr / kenne.alexix@yahoo.fr |
|
Website: |
None |
|
Legal Form: |
Societe Anonyme
Responsabilitee Limitee |
|
|
Date Incorporated: |
14-July-2011 |
|
|
Reg. Number: |
RC/DLA/2011/B/1910 |
|
|
Tax Number: |
M081100039403T |
|
|
Nominal Capital |
CFA.
1,000,000 |
|
|
Subscribed Capital |
CFA.
1,000,000 |
|
|
Subscribed Capital is Subscribed in the following form: |
||
|
|
Position |
Shares |
|
Mr. Alexis Kenne |
MD |
|
|
Mr. Christophe Ampoam |
Director |
|
|
Mr. Ndam amadou |
Director |
|
|
None |
Parent company. |
|
None |
Subsidiary company. |
|
None |
Affiliated company. |
|
None |
Shareholder of subject
firm. |
|
None |
Branches of the firm |
|
Registered to operate
importation and distribution of Medicines, drugs and other similar products |
|
|
Imports: |
Asia, Africa |
|
Exports: |
None |
|
Trademarks: |
None |
|
Terms of sale: |
Cash (40%) and 25-90 days (60%), invoices. |
|
|
|
|
Main Customers: |
Local agencies , Hospitals, Laboratories, and medical Firms |
|
Employees: |
20 employees. |
|
Vehicles: |
Several motor vehicles. |
|
Territory of sales: |
Cameroon |
|
Location: |
Rented premises, 10,000 square feet, |
|
Auditors: |
Information not
available. |
|
Insurance Brokers: |
Information not
available. |
|
|
|
|
Currency Reported: |
West African Franc (CFA.) |
|
|
Approx. Ex. Rate: |
1 US Dollar = 592.77 West
African Franc |
|
|
Fiscal Year End: |
December 31, 2014 |
|
|
Inflation: |
According to information given by independent sources, the inflation
at December 31st, 2014 was of 13%. |
|
|
|
||
|
Financial Information not
Submitted |
|
|
|
|
|
|
|
Profit and Loss
(expressed in CFA.) |
||
|
|
|
2014 |
|
Sales |
|
1,250,000,000 |
|
Bank Name: |
Union
Bank of Cameroon (UBC) |
|
Branch: |
Cameroon |
|
Comments: |
None |
|
This information was
obtained from outside sources other than the subject company itself and
confirmed the above subject. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.20 |
|
|
1 |
Rs.98.30 |
|
Euro |
1 |
Rs.72.41 |
|
Euro |
1 |
Rs.0.11 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a
reference to assess SC’s credit risk and to set the amount of credit to be
extended. It is calculated from a composite of weighted scores obtained from
each of the major sections of this report. The assessed factors and their
relative weights (as indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.